Skip to content
Search

Latest Stories

Mike Hewitson elected as NPA board member for England: New term begins April

The new NPA board will meet in April to confirm the appointments for chair, vice chair, treasurer, and other key positions.

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.


The seat, open to any NPA member with up to five pharmacies, was contested by five candidates:

1.Baba Akomolafe

2.James Famakin

3.Simon Harris

4.Matt Harvey

5.Mike Hewitson

In February, David Thomas, owner of LT Chemists in Newport, was elected as the NPA board member for Wales, succeeding Raj Aggarwal OBE in an uncontested election.

Both Thomas and Hewitson will assume their roles in April, joining 10 existing board members for the new term running from April 2025 to March 2027.

Four members – Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir – were re-elected to the Board in February.

Ashley Cohen, Sanjeev Panesar, Sukhi Basra, Salim Jetha, Olivier Picard, and Nick Kaye continue their terms without needing to stand for election this time. They still have another two years to run on their terms as board members.

For the new term, the NPA board members include:

1.Baldev Bange

2.Sukhi Basra

3.Ashley Cohen

4.Sanjay Ganvir

5.Mike Hewitson

6.Salim Jetha

7.Nick Kaye

8.Aisling O’Brien

9.Sanjeev Panesar

10.Olivier Picard

11.Sehar Shahid (Scotland)

12.David Thomas (Wales)

However, the board seat for Northern Ireland remains undecided as the selection process continues.

As part of the transition, the association bids farewell to several long-serving board members who have reached the maximum term limit under new governance arrangement: Raj Aggarwal OBE, Dr Ian Cubbin, Michael Guerin, Andrew Lane, and Raj Patel MBE.

The new NPA board will meet in April to confirm the appointments for chair, vice chair, treasurer, and other key positions.

Current Chair Nick Kaye welcomed the incoming members, stating: “We welcome the new board members to the dynamic, diverse and determined national leadership of independent community pharmacy”.

“This is a highly challenging period for the entire sector, so it’s great that the board is of such calibre and passionate about supporting and representing independents across the UK.”

He also recognised the contributions of the departing board members, highlighting their dedication and expertise in guiding the organisation and maintaining its century-long position at the heart of independent community pharmacy.

More For You

Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less
Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less